In addition, treatment with RK-33 and CX4945 in PCa cells, which are inhibitors of DDX3X and CSNK2A1 respectively, produced the same results in vitro and in vivo (Figs. 6A–J and S8C–G). The gene discussed is DDX3X; the disease is posterior cortical atrophy.